Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

X‑irradiation induces acute and early term inflammatory responses in atherosclerosis‑prone ApoE‑/‑ mice and in endothelial cells.

Tytuł:
X‑irradiation induces acute and early term inflammatory responses in atherosclerosis‑prone ApoE‑/‑ mice and in endothelial cells.
Autorzy:
Ramadan R; Radiobiology Unit, Belgian Nuclear Research Centre, 2400 Mol, Belgium.
Claessens M; Department of Basic and Applied Medical Sciences, Physiology Group, Ghent University, 9000 Ghent, Belgium.
Cocquyt E; Department of Basic and Applied Medical Sciences, Physiology Group, Ghent University, 9000 Ghent, Belgium.
Mysara M; Microbiology Unit, Belgian Nuclear Research Centre (SCK CEN), 2400 Mol, Belgium.
Decrock E; Department of Basic and Applied Medical Sciences, Physiology Group, Ghent University, 9000 Ghent, Belgium.
Baatout S; Radiobiology Unit, Belgian Nuclear Research Centre, 2400 Mol, Belgium.
Aerts A; Radiobiology Unit, Belgian Nuclear Research Centre, 2400 Mol, Belgium.
Leybaert L; Department of Basic and Applied Medical Sciences, Physiology Group, Ghent University, 9000 Ghent, Belgium.
Źródło:
Molecular medicine reports [Mol Med Rep] 2021 Jun; Vol. 23 (6). Date of Electronic Publication: 2021 Mar 31.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Athens, Greece : D. A. Spandidos
MeSH Terms:
X-Rays*
Apolipoproteins E/*genetics
Atherosclerosis/*metabolism
Chemokine CXCL10/*metabolism
Endothelium, Vascular/*radiation effects
Growth Differentiation Factor 15/*metabolism
Animals ; Apolipoproteins E/deficiency ; Atherosclerosis/genetics ; Cell Adhesion Molecule-1/genetics ; Cell Adhesion Molecule-1/metabolism ; Cell Line ; Cells, Cultured ; Chemokine CCL2/genetics ; Chemokine CCL2/metabolism ; Chemokine CXCL10/genetics ; Endothelial Cells/metabolism ; Endothelial Cells/radiation effects ; Endothelium, Vascular/cytology ; Female ; Fibroblast Growth Factor 1/genetics ; Fibroblast Growth Factor 1/metabolism ; Growth Differentiation Factor 15/genetics ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; P-Selectin/genetics ; P-Selectin/metabolism ; Receptors, Urokinase Plasminogen Activator/genetics ; Receptors, Urokinase Plasminogen Activator/metabolism
References:
Atherosclerosis. 1977 Oct;28(2):197-204. (PMID: 911376)
Oncotarget. 2015 Oct 13;6(31):31263-71. (PMID: 26359350)
J Am Heart Assoc. 2012 Dec;1(6):e002550. (PMID: 23316317)
Circulation. 2007 Jan 30;115(4):450-8. (PMID: 17190864)
Biomed Res Int. 2014;2014:893106. (PMID: 24868552)
J Am Coll Cardiol. 2003 Aug 20;42(4):743-9. (PMID: 12932613)
CA Cancer J Clin. 2016 Jul;66(4):271-89. (PMID: 27253694)
J Exp Med. 2011 Feb 14;208(2):217-25. (PMID: 21242297)
PLoS One. 2015 Mar 23;10(3):e0119661. (PMID: 25799423)
Cell Signal. 2011 Aug;23(8):1299-310. (PMID: 21426933)
Oncotarget. 2016 Feb 23;7(8):8524-31. (PMID: 26885756)
Int J Mol Med. 2016 Dec;38(6):1623-1641. (PMID: 27748824)
World J Cardiol. 2016 Jun 26;8(6):368-74. (PMID: 27354894)
Herz. 2009 Dec;34(8):594-9. (PMID: 20024638)
Growth Factors. 2004 Sep;22(3):157-67. (PMID: 15518239)
J Inflamm (Lond). 2015 Feb 18;12:14. (PMID: 25705130)
Ann ICRP. 2012 Feb;41(1-2):1-322. (PMID: 22925378)
Int J Cardiol. 2017 Apr 15;233:23-28. (PMID: 28189264)
Cancer Res. 1994 May 15;54(10):2582-90. (PMID: 8168084)
Clin Exp Rheumatol. 2019 Jan-Feb;37(1):112-119. (PMID: 29998825)
PLoS One. 2013 Jun 20;8(6):e65486. (PMID: 23840332)
Oncotarget. 2016 Mar 1;7(9):9634-44. (PMID: 26909594)
Clin Breast Cancer. 2018 Oct;18(5):e819-e824. (PMID: 29980429)
Arterioscler Thromb Vasc Biol. 1999 Jun;19(6):1518-25. (PMID: 10364084)
PLoS One. 2017 Apr 18;12(4):e0175130. (PMID: 28419100)
Dis Esophagus. 2008;21(5):437-44. (PMID: 19125798)
Atherosclerosis. 1999 Feb;142(2):265-8. (PMID: 10030376)
Front Cardiovasc Med. 2017 Oct 26;4:66. (PMID: 29124057)
Atherosclerosis. 2009 Apr;203(2):509-14. (PMID: 18701106)
Am J Pathol. 2006 Feb;168(2):649-58. (PMID: 16436678)
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2045-51. (PMID: 22895665)
Mutat Res Rev Mutat Res. 2015 Apr-Jun;764:90-100. (PMID: 26041268)
J Radiat Res. 2011;52(3):287-92. (PMID: 21343678)
Aging Cell. 2014 Oct;13(5):900-10. (PMID: 25059316)
Front Pharmacol. 2020 Mar 05;11:212. (PMID: 32210810)
J Exp Med. 2002 Oct 7;196(7):887-96. (PMID: 12370251)
Radiat Res. 2006 Dec;166(6):819-31. (PMID: 17149971)
Cancer Res. 1996 Nov 15;56(22):5150-5. (PMID: 8912850)
Open Med (Wars). 2017 Jun 16;12:189-194. (PMID: 28730178)
EJC Suppl. 2014 Jun;12(1):18-28. (PMID: 26217163)
Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1859-64. (PMID: 12426216)
Int Heart J. 2016;57(2):134-9. (PMID: 26973275)
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):656-65. (PMID: 20159360)
J Clin Invest. 2001 Feb;107(3):333-40. (PMID: 11160157)
Front Microbiol. 2017 Jan 25;8:55. (PMID: 28179899)
J Biol Chem. 2011 Jun 24;286(25):22665-77. (PMID: 21536666)
PLoS One. 2013;8(2):e57052. (PMID: 23451141)
Biomed Res Int. 2013;2013:408253. (PMID: 24199192)
Cancer Res. 1997 Jun 1;57(11):2096-9. (PMID: 9187101)
Radiat Res. 2011 May;175(5):665-76. (PMID: 21375359)
Int J Cardiol. 2018 Apr 15;257:36. (PMID: 29506733)
Gynecol Endocrinol. 2015;31(8):618-24. (PMID: 26220767)
Radiother Oncol. 2015 Nov;117(2):376-81. (PMID: 26233589)
J Am Coll Cardiol. 2010 Mar 23;55(12):1227-1236. (PMID: 20298930)
Cancer. 2005 Sep 15;104(6):1129-37. (PMID: 16080176)
Int J Radiat Biol. 1997 Aug;72(2):201-9. (PMID: 9269313)
Physiol Genomics. 2007 Nov 14;31(3):402-9. (PMID: 17698927)
Circulation. 2006 May 16;113(19):2301-12. (PMID: 16682613)
Nature. 2000 Sep 14;407(6801):233-41. (PMID: 11001066)
Cardiol Res Pract. 2011 Feb 27;2011:317659. (PMID: 21403872)
Mol Cancer Res. 2014 Jul;12(7):1002-15. (PMID: 24784841)
Radiother Oncol. 2012 Dec;105(3):365-70. (PMID: 23245647)
Lipids Health Dis. 2017 Dec 06;16(1):233. (PMID: 29212549)
Mutat Res. 2016 Oct - Dec;770(Pt B):299-318. (PMID: 27919337)
Biomarkers. 2011 Sep;16(6):466-75. (PMID: 21718220)
Clin Exp Med. 2008 Sep;8(3):141-5. (PMID: 18791686)
BMJ. 2010 Jan 14;340:b5349. (PMID: 20075151)
Radiat Res. 1999 Jul;152(1):6-13. (PMID: 10381836)
Br J Radiol. 2015 Oct;88(1054):20150169. (PMID: 26224431)
Biomed Res Int. 2017;2017:4013685. (PMID: 28349060)
Biomed Pharmacother. 2018 Mar;99:1014-1021. (PMID: 29665642)
J Proteome Res. 2015 Feb 6;14(2):1203-19. (PMID: 25590149)
Am J Cardiol. 2009 Nov 1;104(9):1179-83. (PMID: 19840558)
Radiat Oncol. 2013 Mar 20;8:66. (PMID: 23514369)
Stem Cells. 2000;18(1):65-6. (PMID: 10661575)
BMJ. 2003 Feb 1;326(7383):256-7. (PMID: 12560277)
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11514-9. (PMID: 9326641)
Climacteric. 2016 Oct;19(5):448-51. (PMID: 27427235)
Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):848-57. (PMID: 18514779)
Science. 2002 Jan 18;295(5554):505-8. (PMID: 11799247)
Asia Ocean J Nucl Med Biol. 2015 Winter;3(1):3-9. (PMID: 27408875)
Int J Radiat Biol. 2005 Nov;81(11):821-6. (PMID: 16484151)
Circ Res. 2003 Dec 12;93(12):1267-71. (PMID: 14576203)
PLoS One. 2018 Oct 3;13(10):e0204960. (PMID: 30281653)
Circulation. 2002 Mar 5;105(9):1135-43. (PMID: 11877368)
J Clin Invest. 1999 Oct;104(8):1041-50. (PMID: 10525042)
Curr Heart Fail Rep. 2012 Dec;9(4):337-45. (PMID: 22961192)
Atherosclerosis. 2014 Aug;235(2):510-8. (PMID: 24953491)
Cancer Lett. 2004 Dec 8;216(1):103-7. (PMID: 15500953)
Mol Cell Biol. 2000 May;20(10):3742-51. (PMID: 10779363)
Pract Radiat Oncol. 2018 May - Jun;8(3):e79-e86. (PMID: 28888675)
Sci Rep. 2019 Jun 20;9(1):4643. (PMID: 31217426)
J Atheroscler Thromb. 2010 Feb;17(1):1-11. (PMID: 20032572)
Hematol Oncol Clin North Am. 2006 Apr;20(2):363-400. (PMID: 16730299)
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1580-6. (PMID: 22284687)
Mediators Inflamm. 2018 Jul 19;2018:1975056. (PMID: 30116143)
Health Phys. 2017 Jul;113(1):23-29. (PMID: 28542008)
N Engl J Med. 2013 Mar 14;368(11):987-98. (PMID: 23484825)
Curr Atheroscler Rep. 2015 Jun;17(6):509. (PMID: 25813213)
Int J Med Sci. 2012;9(3):193-9. (PMID: 22408567)
Biomed Res Int. 2015;2015:967680. (PMID: 26351640)
Contributed Indexing:
Keywords: thoracic irradiation; cardiovascular disease; atherosclerosis; systemic inflammation; endothelial inflammation
Substance Nomenclature:
0 (Apoe protein, mouse)
0 (Apolipoproteins E)
0 (Ccl2 protein, mouse)
0 (Cell Adhesion Molecule-1)
0 (Chemokine CCL2)
0 (Chemokine CXCL10)
0 (Cxcl10 protein, mouse)
0 (Gdf15 protein, mouse)
0 (Growth Differentiation Factor 15)
0 (P-Selectin)
0 (Receptors, Urokinase Plasminogen Activator)
104781-85-3 (Fibroblast Growth Factor 1)
Entry Date(s):
Date Created: 20210331 Date Completed: 20210510 Latest Revision: 20210705
Update Code:
20240104
PubMed Central ID:
PMC8025474
DOI:
10.3892/mmr.2021.12038
PMID:
33786610
Czasopismo naukowe
Thoracic radiotherapy is an effective treatment for many types of cancer; however it is also associated with an increased risk of developing cardiovascular disease (CVD), appearing mainly ≥10 years after radiation exposure. The present study investigated acute and early term physiological and molecular changes in the cardiovascular system after ionizing radiation exposure. Female and male ApoE ‑/‑ mice received a single exposure of low or high dose X‑ray thoracic irradiation (0.1 and 10 Gy). The level of cholesterol and triglycerides, as well as a large panel of inflammatory markers, were analyzed in serum samples obtained at 24 h and 1 month after irradiation. The secretion of inflammatory markers was further verified in vitro in coronary artery and microvascular endothelial cell lines after exposure to low and high dose of ionizing radiation (0.1 and 5 Gy). Local thoracic irradiation of ApoE ‑/‑ mice increased serum growth differentiation factor‑15 (GDF‑15) and C‑X‑C motif chemokine ligand 10 (CXCL10) levels in both female and male mice 24 h after high dose irradiation, which were also secreted from coronary artery and microvascular endothelial cells in vitro . Sex‑specific responses were observed for triglyceride and cholesterol levels, and some of the assessed inflammatory markers as detailed below. Male ApoE ‑/‑ mice demonstrated elevated intercellular adhesion molecule‑1 and P‑selectin at 24 h, and adiponectin and plasminogen activator inhibitor‑1 at 1 month after irradiation, while female ApoE ‑/‑ mice exhibited decreased monocyte chemoattractant protein‑1 and urokinase‑type plasminogen activator receptor at 24 h, and basic fibroblast growth factor 1 month after irradiation. The inflammatory responses were mainly significant following high dose irradiation, but certain markers showed significant changes after low dose exposure. The present study revealed that acute/early inflammatory responses occurred after low and high dose thoracic irradiation. However, further research is required to elucidate early asymptomatic changes in the cardiovascular system post thoracic X‑irradiation and to investigate whether GDF‑15 and CXCL10 could be considered as potential biomarkers for the early detection of CVD risk in thoracic radiotherapy‑treated patients.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies